AstraZeneca’s Voydeya has become the first oral Factor ... AZ acquired rights to danicopan as part of its $39 billion acquisition of Alexion in 2021, which also gave it Soliris and Ultomiris.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback